Amgen Pleads Guilty, Pays $762M For Off-Label Promotion Of 4 Drugs

Amgen Pleads Guilty, Pays $762M For Off-Label Promotion Of 4 Drugs

BROOKLYN, N.Y. - Amgen Inc. said Dec. 19 it has pleaded guilty to a federal misbranding misdemeanor and will pay about $762 million in criminal and civil penalties to the federal and 50 state governments to resolve allegations related to its marketing ...read more